Trial Profile
A retrospective observation study evaluating efficacy of Adalimumab in children with Juvenile idiopathic arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- 22 Aug 2016 New trial record